Researchers harness the immune system to fight pancreatic cancer
Wednesday, September 25, 2013 - 12:00
in Health & Medicine
Pancreatic cancer ranks as the fourth-leading cause of cancer death in the United States, and is one of the most deadly forms of cancer, due to its resistance to standard treatments with chemotherapy and radiation therapy and frequently, its late stage at the time of diagnosis. A group of researchers has published results of a clinical trial in which the standard chemotherapy drug for this disease, was paired with an agonist CD40 antibody, resulting in substantial tumor regressions among some patients with advanced pancreatic cancer.